4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-018833
Options or other derivatives
- Director acquired 27,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Brenner Malcolm · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-05-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +27,500 | $4.60 | 2032-05-16 | 27,500 | 27,500 | D |
Loading xslF345X03/doc4.xml…